NUS Price To Operating Cash Flows Ratio from 2010 to 2025

NUS Stock  USD 6.68  0.08  1.18%   
Nu Skin Price To Operating Cash Flows Ratio yearly trend continues to be comparatively stable with very little volatility. Price To Operating Cash Flows Ratio will most likely to outpace its overall moving average this year. From the period from 2010 to 2025, Nu Skin Price To Operating Cash Flows Ratio quarterly data regression had mean square error of  242.27 and mean deviation of  7.75. View All Fundamentals
 
Price To Operating Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
8.13718609
Current Value
13.24
Quarterly Volatility
15.49000637
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0844 or PTB Ratio of 1.12. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.
  
Check out the analysis of Nu Skin Correlation against competitors.

Latest Nu Skin's Price To Operating Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Operating Cash Flows Ratio of Nu Skin Enterprises over the last few years. It is Nu Skin's Price To Operating Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
Price To Operating Cash Flows Ratio10 Years Trend
Pretty Stable
   Price To Operating Cash Flows Ratio   
       Timeline  

NUS Price To Operating Cash Flows Ratio Regression Statistics

Arithmetic Mean8.42
Coefficient Of Variation183.87
Mean Deviation7.75
Media